T1	chemical 25 33	antigens
T2	disease_or_phenotypic_feature 37 43	cancer
T3	disease_or_phenotypic_feature 92 105	renal failure
T4	chemical 126 140	methoxyflurane
T5	chemical 141 151	anesthesia
T6	chemical 177 186	valsartan
T7	chemical 187 196	inhibitor
T8	chemical 230 234	drug
T9	disease_or_phenotypic_feature 239 247	arterial
T10	disease_or_phenotypic_feature 265 278	heart failure
T11	disease_or_phenotypic_feature 323 340	colloid carcinoma
T12	chemical 401 408	antigen
T13	chemical 476 483	antigen
T14	chemical 505 513	collagen
T15	disease_or_phenotypic_feature 514 523	hamartoma
T16	disease_or_phenotypic_feature 527 553	tuberous sclerosis complex
T17	chemical 557 564	dapsone
T18	disease_or_phenotypic_feature 565 581	hypersensitivity
T19	disease_or_phenotypic_feature 582 590	syndrome
T20	disease_or_phenotypic_feature 606 611	fever
T21	disease_or_phenotypic_feature 631 639	vomiting
T22	disease_or_phenotypic_feature 658 667	hepatitis
T23	chemical 759 763	drug
T24	chemical 777 780	FCM
T25	disease_or_phenotypic_feature 836 841	small
T26	disease_or_phenotypic_feature 902 922	cognitive impairment
T27	disease_or_phenotypic_feature 924 943	psychiatric disease
T28	chemical 945 949	drug
T29	chemical 960 967	alcohol
T30	chemical 976 986	Fluoxetine
T31	disease_or_phenotypic_feature 995 1013	movement disorders
T32	disease_or_phenotypic_feature 1064 1073	cataracts
T33	chemical 1089 1093	H-89
T34	chemical 1105 1114	inhibitor
T35	chemical 1142 1151	inhibitor
T36	disease_or_phenotypic_feature 1218 1226	cataract
T37	disease_or_phenotypic_feature 1249 1257	lymphoma
T38	chemical 1309 1317	antigens
T39	chemical 1349 1352	NPY
T40	chemical 1353 1373	receptor antagonists
T41	disease_or_phenotypic_feature 1392 1399	obesity
T42	disease_or_phenotypic_feature 1404 1428	cardiovascular disorders
T43	disease_or_phenotypic_feature 1450 1459	cancerous
T44	chemical 1491 1494	MTX
T45	chemical 1501 1504	MTX
T46	chemical 1513 1521	solution
T47	chemical 1523 1526	MTX
T48	disease_or_phenotypic_feature 1598 1607	neoplasms
T49	chemical 1620 1628	antigens
T50	chemical 1659 1669	fluoxetine
T51	chemical 1671 1681	sertraline
T52	chemical 1686 1697	fluvoxamine
T53	disease_or_phenotypic_feature 1775 1782	obesity
T54	disease_or_phenotypic_feature 1787 1794	obesity
T55	chemical 1796 1810	growth hormone
T56	disease_or_phenotypic_feature 1895 1902	obesity
T57	chemical 1904 1917	Valproic acid
T58	disease_or_phenotypic_feature 1932 1938	cancer
T59	chemical 1939 1943	drug
T60	chemical 2012 2026	Growth hormone
T61	disease_or_phenotypic_feature 2043 2059	islet cell tumor
T62	disease_or_phenotypic_feature 2060 2072	hypoglycemia
T63	disease_or_phenotypic_feature 2117 2127	lung tumor
T64	chemical 2139 2146	antigen
T65	disease_or_phenotypic_feature 2162 2172	lung tumor
T66	disease_or_phenotypic_feature 2186 2193	obesity
T67	chemical 2217 2228	amphetamine
T68	chemical 2230 2237	cocaine
T69	chemical 2242 2250	cannabis
R1	causes_or_contributes_to Arg1:T4 Arg2:T3	
T70	corrected_disease_or_phenotypic_feature 239 260	arterial hypertension
T71	corrected_chemical 177 196	valsartan-inhibitor
T72	corrected_disease_or_phenotypic_feature 557 590	dapsone hypersensitivity syndrome
R4	causes_or_contributes_to Arg1:T17 Arg2:T72	
R5	causes_or_contributes_to Arg1:T23 Arg2:T72	
R6	causes_or_contributes_to Arg1:T23 Arg2:T20	
R7	causes_or_contributes_to Arg1:T23 Arg2:T21	
R8	causes_or_contributes_to Arg1:T23 Arg2:T22	
T73	missed_disease_or_phenotypic_feature 613 621	headache
T74	missed_disease_or_phenotypic_feature 623 629	nausea
T75	missed_disease_or_phenotypic_feature 641 656	lymphadenopathy
T76	missed_disease_or_phenotypic_feature 669 678	hemolysis
T77	missed_disease_or_phenotypic_feature 680 690	leukopenia
T78	missed_disease_or_phenotypic_feature 696 709	mononucleosis
R9	causes_or_contributes_to Arg1:T23 Arg2:T73	
R10	causes_or_contributes_to Arg1:T23 Arg2:T74	
R11	causes_or_contributes_to Arg1:T23 Arg2:T75	
R12	causes_or_contributes_to Arg1:T23 Arg2:T76	
R13	causes_or_contributes_to Arg1:T23 Arg2:T77	
R14	causes_or_contributes_to Arg1:T23 Arg2:T78	
R15	causes_or_contributes_to Arg1:T30 Arg2:T31	
R16	causes_or_contributes_to Arg1:T33 Arg2:T32	
T79	corrected_chemical 1349 1373	NPY receptor antagonists
R17	treats Arg1:T79 Arg2:T41	
R18	treats Arg1:T79 Arg2:T42	
R19	treats Arg1:T52 Arg2:T53	
R20	treats Arg1:T51 Arg2:T53	
R21	treats Arg1:T50 Arg2:T53	
T80	corrected_disease_or_phenotypic_feature 2039 2072	non-islet cell tumor hypoglycemia
R22	treats Arg1:T60 Arg2:T80	
T81	DONE 2264 2268	DONE
T82	corrected_chemical 1614 1628	tumor antigens
T83	corrected_chemical 177 210	valsartan-inhibitor of neprilysin
R2	treats Arg1:T83 Arg2:T70	
R3	treats Arg1:T83 Arg2:T10	
T84	missed_disease_or_phenotypic_feature 768 775	leprosy
R24	treats Arg1:T17 Arg2:T84	
T85	missed_chemical 1095 1121	selective inhibitor of PKA
R25	treats Arg1:T85 Arg2:T32	
T86	missed_chemical 1614 1656	tumor antigens recognized by T lymphocytes
R26	treats Arg1:T86 Arg2:T48	
R23	treats Arg1:T57 Arg2:T58	
